Dr Richard Gordon and assistant in his lab

Researchers from The University of Queensland will investigate the potential of existing drugs to be repurposed to fight Parkinson’s disease thanks to a new research grant.

7 March 2019
(L-R) UQ VC Peter Høj, Professor Perry Bartlett, The Honorable Leeanne Enoch MP, Emeritus Professor Andrew Boyd, Professor Pankaj Sah

A potential drug to treat motor neurone disease (MND) is set to emerge from a partnership between The University of Queensland and the Queensland Government.

20 April 2018
Professor Riccardo Dolcetti and Professor Ranjeny Thomas

Global health care leader MSD has signed an agreement with The University of Queensland to develop a platform for new immuno-oncology therapies.

25 October 2017
The new facility will allow researchers to examine the effects of tiny drug doses in human and animal cancers

New cancer-fighting drugs and devices could emerge from The University of Queensland, thanks to a research program comparing cancers in pet animals and humans in a state-of-the-art imaging facility opened today.

28 March 2017
UQ's research will benefit Queensland and have global impact

University of Queensland researchers are celebrating a combined multi-million-dollar success in the Queensland Government’s Advance Queensland Fellowships scheme.

24 March 2017
The software monitors patients progress before, during and after a hospital stay.

Innovative software developed at The University of Queensland can now be used to improve aged care worldwide, with leading global health care company Raisoft signing a non-exclusive license.

8 December 2015
Professor Maree Smith (centre), with Johnson & Johnson Medical CEO Gavin Fox-Smith and AusBiotech CEO Dr Anna Lavelle

The University of Queensland’s Professor Maree Smith and the company founded on the ground-breaking pain drug she developed have won awards at the AusBiotech 2015 Conference.

7 October 2015
The collaboration fosters medical innovation by bringing together complementary skills.

Pharmaceutical company AstraZeneca and UniQuest have formed an “open innovation” program to support academic research that holds promise of new therapeutic drugs.

30 April 2015